×
Site Menu
Everything
Politics
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Health
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
3 months ago
68
The EU support of Imfinzi for early-stage gastric and gastroesophageal cancers expands the statement of 1 of the company’s top-selling oncology medicines.
Read Entire Article
Homepage
Technology
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
Related
Meta Ordered by E.U. to Alter ‘Addictive Design’ of Instagra...
7 hours ago
2
Opinion | Will Washington State Choose Stagnation Over Growt...
8 hours ago
2
SK Hynix rises 14% in debut on Wall Street as demand for mem...
8 hours ago
2
Popular
A walk through Taylor Swift’s New York on her wedding day.
6 days ago
15
Scientist dubbed The Bogfather is restoring peatland to figh...
6 days ago
15
Turbines turning from wind to sustainable products
6 days ago
15
As dementia complicates caregiving, families confront a pain...
6 days ago
15
President Trump spoke in front of Mount Rushmore ahead of th...
6 days ago
14